Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid

Hormone and Metabolic Research

Volumn 40, Issue 1, 2008, Pages 60-65

  Kaji, H ^a   Yamauchi, M ^b   Chihara, K ^a   Sugimoto, T ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Glucocorticoid; Osteoporosis; Parathyroid hormone

Indexed keywords

DEOXYPYRIDINOLINE; GLUCOCORTICOID; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISOLONE;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; URINE LEVEL; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; RETROSPECTIVE STUDIES; SPINAL FRACTURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38849128842     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993170     Document Type: Article

References (38)

1. Rubin MR, Bilezikian JP. The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 2002; 87: 4033-4041
2. Mazziotti G, Angeli A, Bilezikian JP, Canalis E. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 2006; 17: 144-149
3. Ross EJ, Linch DC. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982; 2: 646-649
4. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265-268
5. Bressot C, Meunier J, Lejeune E, Edouard C, Darby A. Histomorphometric profile, pathophysiology and reversibility of glucocorticoid-induced osteoporosis. Metabolic Bone Dis Rel Res 1979; 1: 303-311
6. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 2003; 88: 2655-2658
7. Nakaoka D, Sugimoto T, Kaji H, Kanzawa M, Yano S, Yamauchi M, Sugishita T, Chihara K. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women. Osteoporos Int 2001; 12: 548-554
8. Smith-Bindman R, Cummings SR, Steiger P, Genant HK. A comparison of morphometric definitions of vertebral fractures. J Bone Miner Res 1991; 6: 25-34
9. Ruegsegger P, Durand E, Dambacher MA. Localization of regional forearm bone loss from high-resolution computed tomographic images. Osteoporos Int 1991; 1: 76-80
10. Kaji H, Kosaka R, Yamauchi M, Kuno K, Chihara K, Sugimoto T. Effects of age, grip strength and smoking on forearm volumetric bone mineral density and bone geometry by peripheral quantitative computed tomography: comparisons between female and male. Endocr J 2005; 52: 659-666
11. Kaji H, Iu MF, Naito J, Sugimoto T, Chihara K. A case of primary hyperparathyroidism with the marked change of bone mimerai density and bone morphometry after parathyroidectomy. J Bone Miner Metab 2006; 24: 349-352
12. Shchiessl H, Ferretti JL, Tysarczyk-Niemeyer G. Noninvasive bone strength index as analysis by peripheral quantitative computed tomography (pQCT). In: Schonau E (ed). Pediatric osteology. New developments in diagnostics and therapy. Amsterdam: Elsevier, 1996;147-160
13. Lane NE, Lukert B. The science and therapy of glucocorticoid- induced bone loss. Endoicrinol Metab Clin North Am 1998; 27: 465-483
14. Lund B, Storm TL, Melsen F, Mosekilde L, Andersen RB, Egmose C, Sorensen OH. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheumatol 1985; 4: 143-149
15. Suzuki Y, Ishikawa Y, Saito E, Honma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidsm of patients under glucocorticoid therapy. Metabolism 1983; 32: 151-156
16. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979; 64: 655-665
17. Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV. Effects of prednisone and defrazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 1984; 36: 245-252
18. Lukert BP, Adams JS. Calcium and phosphorus homeostasis in man. Effect of glucocorticoids. Arch Intern Med 1976; 136: 1249-1253
19. Cosman F, Nieves J, Herbert J, Shen V, Lidsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994; 9: 1097-1105
20. Paz-Pacheco E, El-haji Fuleihan G, Leboff MS. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J Bone Miner Res 1995; 10: 1713-1718
21. Kaji H, Tobimatsu T, Naito J, Iu MF, Yamauchi M, Sugimoto T, Chihara K. Body composition and vertebral fracture risk in female patients treated with glucocorticoid. Osteoporos Int 2006; 17: 627-633
22. Hattersley AT, Meeran K, Burrin J, Hill P, Shiner R, Ibbertson HK. The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int 1994; 54: 198-202
23. Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E. Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 1998; 83: 801-806
24. Kaji H, Yamauchi M, Chihara K, Sugimoto T. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid -induced osteoporosis. Endocr J 2006; 53: 27-34
25. Kaji H, Yamauchi M, Chihara K, Sugimoto T. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. Eur J Endocrinol 2005; 153: 373-378
26. Kaji H, Nomura R, Yamauchi M, Chihara K, Sugimoto T. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism. Horm Metab Res 2006; 38: 411-416
27. Yamamoto I, Potts Jr JT, Segre GV. Glucocorticoid increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (ROS 17/2). J Bone Miner Res 1988; 3: 707-712
28. Urena P, Iida-Klein A, Juppner H, Kronenberg HM, Abou-Samra AB, Segre GV. Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells. Endocrinology 1994; 134: 451-456
29. Majeska RJ, Nair BC, Rodan GA. Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8. Endocrinology 1985; 116: 170-179
30. Kaji H, Sugimoto T, Kanatani M, Nishiyama K, Chihara K. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. J Bone Miner Res 1997; 12: 734-741
31. Conaway HH, Grigorie D, Lerner UH. Differential effects of glucocorticoids on bone resorption in neonatal mouose calvariae stimulated by peptide and steroid-like hormones. J Endocrinol 1997; 155: 513-521
32. Bonadonna S, Burattin A, Nuzzo M, Bugari G, Rosei EA, Valle D, Iori N, Bilezikian JP, Veldhuis JD, Giustina A. Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. Eur J Endocrinol 2005; 152: 199-205
33. Lehman R, Wapniarz M, Kvasnicka HM, Baedeker S, Klein K, Allolio B. Reproducibility of bone density measurements of the distal radius using a high resolution special scanner for peripheral quantitative computed tomography (Single Energy PQCT). Radiology 1992; 32: 177-181
34. Zanchetta J, Bogado C, Ferretti J, Wang O, Wilson M, Sato M, Gaich G, Dalsky G, Myers S. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 2003; 18: 539-543
35. Hirano T, Burr DB, Cain RL, Hock JM. Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34). Calcif Tissue Int 2000; 66: 456-460
36. Laan RFJM, Buijs WCAM, Erning TJTO, Lemmens JAM, Corstens FHM, Ruijs SHJ, Putte LBA, Riel PLCM. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 1993; 52: 5-9
37. Tsugeno H, Goto B, Fujita T, Okamoto M, Mifune T, Mitsunobu F, Ashida K, Hosaki Y, Tsuji T, Tanizaki Y. Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients. Osteoporos Int 2001; 12: 266-270
38. Tsugeno H, Fujita T, Goto B, Sugishita T, Hosaki Y, Ashida K, Mitsunobu F, Tanizaki Y, Shiratori Y. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis. Osteoporos Int 2002; 13: 650-656